EUVIMEDEUVIMED entdecken
Open Access

Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling

Gwo-Jyh Chang iD, Wei-Jan Chen iD, Yu-Juei Hsu iD, Ying-Hwa Chen iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Gwo-Jyh Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Medicinal Sciences Chang-Gung University College of Medicine Tao-Yuan Taiwan. Hauptthemen laut MEDLINE: Glucosides, Neointima, Benzhydryl Compounds, Cell Proliferation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular events. However, the precise mechanisms beyond glycemic control are not fully understood. The objective of this study was to determine the role of PDGF (platelet‐derived growth factor)–related signaling in empagliflozin‐mediated inhibition of neointima formation. Methods and Results Adult male nondiabetic Wistar rats were subjected to carotid artery balloon injury. Empagliflozin (30 mg/kg per day) was administered by oral gavage for 18 days beginning 4 days before surgery. The in vitro effects of empagliflozin on rat aortic vascular smooth muscle cell (VSMC) proliferation and migration were also determined. Empagliflozin attenuated balloon injury–induced neointima formation in carotid arteries. In VSMCs, empagliflozin attenuated PDGF‐BB‐induced proliferation and migration. Moreover, empagliflozin‐treated VSMCs did not undergo apoptosis or cytotoxic death. Empagliflozin suppressed PDGF‐related signaling, including phosphorylation of PDGF receptor β, Akt, and STAT3 (signal transducer and activator of transcription 3). Overactivation of PDGF signaling attenuated empagliflozin‐mediated inhibition of VSMC function. SGLT2 mRNA levels in rat VSMCs were undetectable, and SGLT2 silencing did not alter the empagliflozin‐mediated effects, supporting the SGLT2‐independent effects of empagliflozin on VSMC.

Conclusions

This study highlights the crucial role of suppressing PDGF‐related signaling in mediating the beneficial effects of empagliflozin on neointima formation and VSMC function, which are independent of SGLT2 and glycemic control. Our study provides a novel mechanistic aspect of empagliflozin for the prevention of vascular stenosis disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosidesNeointimaBenzhydryl CompoundsCell ProliferationCell MovementSignal TransductionCarotid Artery InjuriesRats, WistarMuscle, Smooth, VascularMyocytes, Smooth MuscleSodium-Glucose Transporter 2 InhibitorsAnimalsMaleCells, CulturedDisease Models, AnimalPhosphorylationSTAT3 Transcription FactorRatsProto-Oncogene Proteins c-aktBecaplerminReceptor, Platelet-Derived Growth Factor betaPlatelet-Derived Growth Factor

Stichwörter der Autor:innen

empagliflozinneointima formationplatelet‐derived growth factorsodium–glucose cotransporter 2vascular smooth muscle cells

Substanzen

empagliflozinGlucosidesBenzhydryl CompoundsSodium-Glucose Transporter 2 InhibitorsSTAT3 Transcription FactorStat3 protein, ratProto-Oncogene Proteins c-aktBecaplerminReceptor, Platelet-Derived Growth Factor betaPlatelet-Derived Growth Factor

Autor:innen und Institutionen

  • Graduate Institute of Clinical Medicinal Sciences Chang-Gung University College of Medicine Tao-Yuan Taiwan.
  • Cardiovascular Division, Chang-Gung Memorial Hospital Chang-Gung University College of Medicine Tao-yuan Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital National Defense Medical Center Taipei Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital National Yang Ming Chiao Tung University College of Medicine Taipei Taiwan.

ORCID-Profile: Gwo-Jyh Chang, Wei-Jan Chen, Yu-Juei Hsu, Ying-Hwa Chen

Zitieren

APA

Chang, G. J., Chen, W. J., Hsu, Y. J., & Chen, Y. H. (2024). Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035044

Vancouver

Chang GJ, Chen WJ, Hsu YJ, Chen YH. Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035044

BibTeX
@article{Chang2024,
  author = {Chang, Gwo-Jyh and Chen, Wei-Jan and Hsu, Yu-Juei and Chen, Ying-Hwa},
  title = {Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet‐Derived Growth Factor–Related Signaling},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035044}
}
Kostenlos starten →